LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice

Authors

Jong-Gil Park, Korea Research Institute of Bioscience & Biotechnology
Se-Jin Jeong, Washington University School of Medicine in St. Louis
Jinha Yu, Seoul National University
Gyudong Kim, Seoul National University
Lak Shin Jeong, Seoul National University
Goo Taeg Oh, Ewha Womans University

Journal

BMB Reports

Publication Date

2018

Volume

51

Issue

10

Inclusive Pages

520-525

Document Type

Open Access Publication

DOI

10.5483/BMBRep.2018.51.10.098

Rights and Permissions

Park JG, Jeongs SJ, Yu J, Kim G, Jeong LS, , Oh GT. LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice. BMB Reports 2018;51:520-525. https://doi.org/10.5483/BMBRep.2018.51.10.098 © Korean Society for Biochemistry and Molecular Biology. All rights reserved. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Park, Jong-Gil; Jeong, Se-Jin; Yu, Jinha; Kim, Gyudong; Jeong, Lak Shin; and Oh, Goo Taeg, "LJ-1888, a selective antagonist for the A3 adenosine receptor, ameliorates the development of atherosclerosis and hypercholesterolemia in apolipoprotein E knock-out mice." BMB Reports. 51, 10. 520-525. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/7665